Literature DB >> 18368467

Association of chemokine CCL5 and systemic malignancies.

Shailendra Kapoor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18368467     DOI： 10.1007/s10038-008-0270-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN： 1434-5161            Impact factor:   3.172


× No keyword cloud information.
  10 in total

Review 1.  The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Authors:  Neora Yaal-Hahoshen; Sima Shina; Leonor Leider-Trejo; Itay Barnea; Esther L Shabtai; Elina Azenshtein; Iulia Greenberg; Iafa Keydar; Adit Ben-Baruch
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

2.  Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.

Authors:  G Luboshits; S Shina; O Kaplan; S Engelberg; D Nass; B Lifshitz-Mercer; S Chaitchik; I Keydar; A Ben-Baruch
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

3.  Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival.

Authors:  Sara Ek; Erik Björck; Carl-Magnus Högerkorp; Magnus Nordenskjöld; Anna Porwit-MacDonald; Carl A K Borrebaeck
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

4.  Expression of CCL5 (RANTES) and CCR5 in prostate cancer.

Authors:  Gayle G Vaday; Donna M Peehl; Pournima A Kadam; Diana M Lawrence
Journal:  Prostate       Date:  2006-02-01       Impact factor: 4.104

5.  Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies.

Authors:  M Civatte; C Bartoli; N Schleinitz; B Chetaille; J F Pellissier; D Figarella-Branger
Journal:  Neuropathol Appl Neurobiol       Date:  2005-02       Impact factor: 8.090

6.  Inhibition of metastasis by inhibition of tumor-derived CCL5.

Authors:  Kerry A Stormes; Charles A Lemken; James V Lepre; Michelle N Marinucci; Robert A Kurt
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

7.  Association of CC chemokine ligand 5 genotype with urinary albumin excretion in the non-diabetic Japanese general population: the Takahata study.

Authors:  Tsuneo Konta; Mitsuru Emi; Sayumi Toriyama; Hideto Ariumi; Miho Ishii; Satoshi Takasaki; Ami Ikeda; Kazunobu Ichikawa; Yoko Shibata; Noriaki Takabatake; Yasuchika Takeishi; Takeo Kato; Sumio Kawata; Isao Kubota
Journal:  J Hum Genet       Date:  2008-01-24       Impact factor: 3.172

8.  Elevated expression of CCL5/RANTES in adult T-cell leukemia cells: possible transactivation of the CCL5 gene by human T-cell leukemia virus type I tax.

Authors:  Naoki Mori; Alan M Krensky; Koichi Ohshima; Mariko Tomita; Takehiro Matsuda; Takao Ohta; Yasuaki Yamada; Masao Tomonaga; Shuichi Ikeda; Naoki Yamamoto
Journal:  Int J Cancer       Date:  2004-09-10       Impact factor: 7.396

9.  Infiltration of CD8+ T cells containing RANTES/CCL5+ cytoplasmic granules in actively inflammatory lesions of human chronic gastritis.

Authors:  Noriko Ohtani; Haruo Ohtani; Takashi Nakayama; Hiroshi Naganuma; Eiichi Sato; Toshio Imai; Hiroshi Nagura; Osamu Yoshie
Journal:  Lab Invest       Date:  2004-03       Impact factor: 5.662

10.  Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.

Authors:  Donatella Aldinucci; Debora Lorenzon; Lara Cattaruzza; Antonio Pinto; Annunziata Gloghini; Antonino Carbone; Alfonso Colombatti
Journal:  Int J Cancer       Date:  2008-02-15       Impact factor: 7.396
  10 in total
  1 in total

1.  Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase.

Authors:  Russell W Jenkins; Christopher J Clarke; Daniel Canals; Ashley J Snider; Christopher R Gault; Linda Heffernan-Stroud; Bill X Wu; Fabio Simbari; Patrick Roddy; Kazuyuki Kitatani; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.